BackHUTCHMED (China) Limited Overview
HUTCHMED (China) Limited - ADR

HUTCHMED (China) Limited Target Price

Analysts' average 12-month price target for HUTCHMED (China) Limited is $23.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.94

Average Target Price

$22.7763.4% upside

4 analysts in the last 4 months

High: $45 | Low: $13.6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09Stifel NicolausJames Condulis$45222.8% upsideOpen
2026-09-03DaiwaJing Yang$18.532.7% upsideOpen
2026-07-23Goldman Sachs$140.4% upsideOpen
2026-05-28Morgan Stanley$13.62.4% downsideOpen
2024-05-14Morgan StanleyJack Lin$17.525.5% upsideOpen

HUTCHMED (China) Limited (HCM) FAQ

HUTCHMED (China) Limited (HCM) currently reports a target price of $23. Use the charts on this page to explore HUTCHMED (China) Limited's target price history and peer comparisons.

Analysts' average 12-month price target for HUTCHMED (China) Limited is $23, about 63.4% upside from the current share price of $13.94. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $23, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HUTCHMED (China) Limited, and consider following HCM for alerts when major investors trade the stock.

HUTCHMED (China) Limited is classified in the Healthcare sector. On target price, it currently shows $23. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HCM with unrelated industries.